methotrexate 200 MG in 8 ML Injection
- RxCUI
- 1655968
- RxNorm name
- methotrexate 200 MG in 8 ML Injection
- Display name
- methotrexate 200 MG in 8 ML Injection
- Full name
- methotrexate 200 MG in 8 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METHOTREXATE | METHOTREXATE | Eugia US LLC | 63bb6fbf-dd59-4edc-af8f-d0c397ca1262 | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | 1655968 |
| Methotrexate | METHOTREXATE | Hikma Pharmaceuticals USA Inc. | 3989d30d-56e5-4e8d-9379-c30fecc894f2 | 2023-04-17 | Boxed warning, Warnings, Adverse reactions | 1655968 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3989d30d-56e5-4e8d-9379-c30fecc894f2 | methotrexate 200 MG in 8 ML Injection [PSN] · 8 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 200 MG per 8 ML Injection [SY] | 3 | 9 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20230417 |
| 63bb6fbf-dd59-4edc-af8f-d0c397ca1262 | methotrexate 200 MG in 8 ML Injection [PSN] · 8 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 200 MG per 8 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20250710 |